PreferUS Healthcare and Zhejiang BangEr Orthopedic Hospital

Contact: David Franz
Marketing Manager
Cell: 816-588-6062
Email: dfranz@preferushc.com
PreferUS Healthcare and Zhejiang BangEr Orthopedic Hospital Group Ink Deal to
Secure Positive Future Growth
Shanghai, China (March 24, 2015) - PreferUS Healthcare and Zhejiang BangEr Orthopedic Hospital Group have
officially signed a Definitive Agreement that will allow PreferUS access into BangEr’s brand new 400-bed
orthopedic hospital in Jia Xing City, located in the Zhe Jiang Province which will serve as their regional hub
hospital. Currently, BangEr has 5 smaller hospitals in surrounding provinces that will act as a “feeder system,”
for high-end patients and complicated surgical procedures into the regional hub hospital. In this new hospital,
PreferUS will have the opportunity to build out a 25-bed VIP International Center where they will bring their U.S.
surgeons, western management expertise, protocols, procedures and partner with prominent Chinese surgeons.
BangEr, whose lead investor is Fidelity Growth Partners Asia, has spent over 18 months working with BangEr to
add a great deal of professionalism and strengthen their future strategic plan. Additionally, BangEr has an
exclusive deal with Fidelity stating that Fidelity cannot participate in other orthopedic hospitals in China.
PreferUS believes this statement of trust and commitment is very important to be a part of as they continue to
build their presence in the China healthcare market. The target opening for the PreferUS International Center is
September 2015.
PreferUS Founder and CEO, Michael Franz said, “We are very pleased to bring our cooperation with BangEr and
their lead investor, Fidelity Growth Partners Asia. The proven capabilities of BangEr with their initial five
hospitals and soon to be ten hospitals gives us great confidence that our International Center will be a success and
will lead to expanded opportunities with BangEr.”
About PreferUS Healthcare
PreferUS Healthcare is a group of over 100 U.S. orthopedic surgeons and cardiologists committed to delivering
the most advanced international medical services to the China marketplace. Their scope of services will cater to
a target market consisting of: affluent Chinese, expatriates and medical tourists. Today, PreferUS has established
relationships with three world-renowned institutions in the U.S., where they will train and educate their Chinese
surgeon-partners. In 2008, PreferUS entered the Chinese healthcare market with the intention of learning the
China healthcare landscape with an ultimate goal of finding the optimum fit between western practices and
Chinese cultural tendencies. PreferUS has also established important relationships with several of China’s most
senior orthopedic key opinion leaders. These relationships will be significant as PreferUS and BangEr share a
vision and a strong work ethic to establish a chain of top private orthopedic surgery hospitals across China. The
collaborative efforts will make for a unique offering to the Chinese healthcare market.
About Zhejiang BangEr Orthopedic Hospital Group
Zhejiang BangEr Orthopedic Hospital Group, located south of Shanghai, currently has five hospitals in their
ownership stage with two more hospital licenses secured. With a goal of being a national power in the orthopedic
hospital sector, they are beginning to expand in their respective region and scale at a fast pace. BangEr
demonstrates well-defined competitive strengths and represents a unique investment opportunity among private
orthopedic hospitals in China. Fidelity Growth Partners Asia has been heavily invested in Greater China for over
18 years, Fidelity Growth Partners Asia (“FGPA”), previously known as “Fidelity Asia Ventures”, is one of the
earliest venture capital funds active in this region. With investment teams in Beijing, Shanghai and Hong Kong,
they have established a firm presence in Greater China. Fidelity has successfully invested in, provided years of
strategic and tactical guidance to and exited from numerous portfolio companies including; Alibaba, WuXi
PharmaTech, AsiaInfo and iSoftStone where they were, in each case, the earliest venture investors.
PreferUS Healthcare, LLC. 2015 www.preferushc.com